AR082865A1 - Derivados de triazolo[4,3-a]piridina, y sus usos - Google Patents
Derivados de triazolo[4,3-a]piridina, y sus usosInfo
- Publication number
- AR082865A1 AR082865A1 ARP110103195A ARP110103195A AR082865A1 AR 082865 A1 AR082865 A1 AR 082865A1 AR P110103195 A ARP110103195 A AR P110103195A AR P110103195 A ARP110103195 A AR P110103195A AR 082865 A1 AR082865 A1 AR 082865A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- ring
- formula
- substituent
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Composición farmacéutica, y moduladores de la producción de g secretasa superior, para tratar el mal de Alzheimer.Reivindicación 1: Un compuesto representado por la fórmula (1) caracterizado porque el anillo A es un anillo oxazol opcionalmente sustituido, un anillo triazol opcionalmente sustituido, un anillo imidazol opcionalmente sustituido, un anillo piridina opcionalmente sustituido, o un anillo pirazol opcionalmente sustituido; el anillo B es un anillo benceno opcionalmente sustituido, un anillo piridina opcionalmente sustituido, o un anillo pirimidina opcionalmente sustituido; y la estructura parcial de fórmula (2) es un resto de fórmula (3) ó (4) donde R1 y R2 son iguales o diferentes y cada uno es un sustituyente; L es un enlace, -Y-, -O-, -YO-, -OY-, -S-, -SO-, -SO2-, -CONRa-, -NRaCO-, -NRa-, -YNRa-, -NRaY-, -YCONRa-, -NRaCOY-, -OCONRa-, -NRaCOO- o -NRbCONRa- donde Y es un grupo alquileno C1-6 opcionalmente sustituido, Ra es un átomo de hidrógeno o un grupo alquilo C1-6 opcionalmente sustituido, Rb es un átomo de hidrógeno o un grupo alquilo C1-6 opcionalmente sustituido, R3 es un sustituyente, y n es un entero de 0 - 6; o una sal del mismo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010197064 | 2010-09-02 | ||
JP2011143548 | 2011-06-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR082865A1 true AR082865A1 (es) | 2013-01-16 |
Family
ID=45094181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110103195A AR082865A1 (es) | 2010-09-02 | 2011-09-01 | Derivados de triazolo[4,3-a]piridina, y sus usos |
Country Status (21)
Country | Link |
---|---|
US (3) | US8901309B2 (es) |
EP (1) | EP2611805A1 (es) |
JP (1) | JP5871909B2 (es) |
KR (1) | KR20130139895A (es) |
CN (1) | CN103249733A (es) |
AR (1) | AR082865A1 (es) |
AU (1) | AU2011296887A1 (es) |
BR (1) | BR112013004746A2 (es) |
CA (1) | CA2809779A1 (es) |
CL (1) | CL2013000575A1 (es) |
DO (1) | DOP2013000051A (es) |
EA (1) | EA201390333A1 (es) |
EC (1) | ECSP13012535A (es) |
MA (1) | MA34556B1 (es) |
MX (1) | MX2013002511A (es) |
PE (1) | PE20131305A1 (es) |
SG (1) | SG187917A1 (es) |
TW (1) | TW201213327A (es) |
UY (1) | UY33586A (es) |
WO (1) | WO2012029991A1 (es) |
ZA (1) | ZA201301929B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102482276A (zh) * | 2009-07-13 | 2012-05-30 | 武田药品工业株式会社 | 杂环化合物及其用途 |
EA201390333A1 (ru) * | 2010-09-02 | 2013-08-30 | Такеда Фармасьютикал Компани Лимитед | Конденсированные триазолы для лечения или профилактики умеренного когнитивного нарушения |
EP2687528A1 (en) * | 2012-07-17 | 2014-01-22 | Ares Trading S.A. | Fused triazole derivatives as gamma secretase modulators |
RU2563254C2 (ru) * | 2013-07-08 | 2015-09-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Способ получения производных 7-(гетеро)арил-4,5,6,7-тетрагидро[1,2,3]триазоло[1,5-a]пиридина |
EP3650430A1 (en) * | 2015-05-12 | 2020-05-13 | FMC Corporation | Intermediates and processes for the synthesis of herbicides |
US11603440B2 (en) * | 2019-09-12 | 2023-03-14 | Dupont Electronics, Inc. | Polyimide films and electronic devices |
TW202339756A (zh) * | 2021-12-17 | 2023-10-16 | 美商雅斯娜製藥公司 | 雙環化合物用於治療疾病之用途 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1261610A2 (en) | 2000-02-17 | 2002-12-04 | Bristol-Myers Squibb Pharma Company | Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production |
CA2525547C (en) | 2003-05-14 | 2012-07-03 | Torreypines Therapeutics, Inc. | Compounds and uses thereof in modulating amyloid beta |
PL1678172T3 (pl) * | 2003-10-15 | 2010-05-31 | Targacept Inc | Związki azabicykliczne do łagodzenia bólu oraz leczenia zaburzeń centralnego układu nerwowego |
JP4101852B2 (ja) | 2004-05-26 | 2008-06-18 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | シンナミド化合物 |
ES2338904T3 (es) | 2004-10-26 | 2010-05-13 | EISAI R&D MANAGEMENT CO., LTD. | Forma amorfa de compuestos de cinamida. |
WO2007081897A2 (en) | 2006-01-11 | 2007-07-19 | Merck & Co., Inc. | Fused triazole tachykinin receptor antagonists |
PL1992618T3 (pl) | 2006-03-09 | 2012-06-29 | Eisai R&D Man Co Ltd | Policykliczna pochodna cynamidowa |
TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
TW200808800A (en) | 2006-05-05 | 2008-02-16 | Astrazeneca Ab | MGluR5 modulators V |
US8143394B2 (en) | 2006-12-26 | 2012-03-27 | Gilead Sciences, Inc. | Pyrido(3,2-d)pyrimidines useful for treating viral infections |
WO2008078725A1 (ja) | 2006-12-26 | 2008-07-03 | Daiichi Sankyo Company, Limited | チアゼピン誘導体 |
WO2008097538A1 (en) | 2007-02-08 | 2008-08-14 | Merck & Co., Inc. | Therapeutic agents |
CA2707712A1 (en) | 2007-12-06 | 2009-06-11 | Schering Corporation | Gamma secretase modulators |
TW201030002A (en) * | 2009-01-16 | 2010-08-16 | Bristol Myers Squibb Co | Bicyclic compounds for the reduction of beta-amyloid production |
JP2010197064A (ja) | 2009-02-23 | 2010-09-09 | Chugoku Electric Power Co Inc:The | 直下位置測定装置 |
JP2012051806A (ja) * | 2009-02-26 | 2012-03-15 | Eisai R & D Management Co Ltd | イミダゾリルピラジン誘導体 |
JP2012051807A (ja) | 2009-02-26 | 2012-03-15 | Eisai R & D Management Co Ltd | アリールイミダゾール化合物 |
PE20120172A1 (es) * | 2009-02-26 | 2012-03-08 | Eisai Randd Man Co Ltd | Compuestos heterociclicos fusionados que contiene nitrogeno como inhibidores de la produccion de beta-amiloide |
WO2011002067A1 (ja) | 2009-07-02 | 2011-01-06 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
CN102482276A (zh) * | 2009-07-13 | 2012-05-30 | 武田药品工业株式会社 | 杂环化合物及其用途 |
US8946266B2 (en) | 2009-07-15 | 2015-02-03 | Janssen Pharmaceuticals, Inc. | Substituted triazole and imidazole derivatives as gamma secretase modulators |
TWI468402B (zh) | 2009-07-31 | 2015-01-11 | 必治妥美雅史谷比公司 | 降低β-類澱粉生成之化合物 |
US8637525B2 (en) | 2009-07-31 | 2014-01-28 | Bristol-Myers Squibb Company | Compounds for the reduction of beta-amyloid production |
WO2011016559A1 (ja) | 2009-08-07 | 2011-02-10 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
JP2011143548A (ja) | 2010-01-12 | 2011-07-28 | Panasonic Corp | スクリーン印刷機及びスクリーン印刷方法 |
EP2523949B1 (en) | 2010-01-15 | 2014-08-20 | Janssen Pharmaceuticals Inc. | Novel substituted triazole derivatives as gamma secretase modulators |
EA201390333A1 (ru) * | 2010-09-02 | 2013-08-30 | Такеда Фармасьютикал Компани Лимитед | Конденсированные триазолы для лечения или профилактики умеренного когнитивного нарушения |
-
2011
- 2011-09-01 EA EA201390333A patent/EA201390333A1/ru unknown
- 2011-09-01 KR KR1020137008170A patent/KR20130139895A/ko not_active Application Discontinuation
- 2011-09-01 MA MA35785A patent/MA34556B1/fr unknown
- 2011-09-01 MX MX2013002511A patent/MX2013002511A/es not_active Application Discontinuation
- 2011-09-01 AU AU2011296887A patent/AU2011296887A1/en not_active Abandoned
- 2011-09-01 WO PCT/JP2011/070419 patent/WO2012029991A1/en active Application Filing
- 2011-09-01 AR ARP110103195A patent/AR082865A1/es unknown
- 2011-09-01 PE PE2013000360A patent/PE20131305A1/es not_active Application Discontinuation
- 2011-09-01 CA CA2809779A patent/CA2809779A1/en not_active Abandoned
- 2011-09-01 UY UY0001033586A patent/UY33586A/es unknown
- 2011-09-01 SG SG2013012604A patent/SG187917A1/en unknown
- 2011-09-01 US US13/819,239 patent/US8901309B2/en not_active Expired - Fee Related
- 2011-09-01 EP EP11791058.8A patent/EP2611805A1/en not_active Withdrawn
- 2011-09-01 CN CN2011800518621A patent/CN103249733A/zh active Pending
- 2011-09-01 TW TW100131443A patent/TW201213327A/zh unknown
- 2011-09-01 BR BR112013004746A patent/BR112013004746A2/pt not_active IP Right Cessation
- 2011-09-01 US US13/223,455 patent/US8822699B2/en not_active Expired - Fee Related
- 2011-09-01 JP JP2013510386A patent/JP5871909B2/ja not_active Expired - Fee Related
-
2013
- 2013-02-28 CL CL2013000575A patent/CL2013000575A1/es unknown
- 2013-03-01 DO DO2013000051A patent/DOP2013000051A/es unknown
- 2013-03-14 ZA ZA2013/01929A patent/ZA201301929B/en unknown
- 2013-03-28 EC ECSP13012535 patent/ECSP13012535A/es unknown
-
2014
- 2014-08-08 US US14/454,993 patent/US20140350260A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2011296887A1 (en) | 2013-04-11 |
UY33586A (es) | 2012-03-30 |
PE20131305A1 (es) | 2013-10-31 |
MA34556B1 (fr) | 2013-09-02 |
CL2013000575A1 (es) | 2013-08-23 |
US20120059030A1 (en) | 2012-03-08 |
US8901309B2 (en) | 2014-12-02 |
US8822699B2 (en) | 2014-09-02 |
TW201213327A (en) | 2012-04-01 |
WO2012029991A1 (en) | 2012-03-08 |
BR112013004746A2 (pt) | 2016-06-07 |
JP2013536798A (ja) | 2013-09-26 |
ECSP13012535A (es) | 2013-06-28 |
CN103249733A (zh) | 2013-08-14 |
ZA201301929B (en) | 2013-11-27 |
KR20130139895A (ko) | 2013-12-23 |
DOP2013000051A (es) | 2013-04-30 |
EA201390333A1 (ru) | 2013-08-30 |
US20140350260A1 (en) | 2014-11-27 |
MX2013002511A (es) | 2013-07-29 |
JP5871909B2 (ja) | 2016-03-01 |
US20130178497A1 (en) | 2013-07-11 |
SG187917A1 (en) | 2013-04-30 |
EP2611805A1 (en) | 2013-07-10 |
CA2809779A1 (en) | 2012-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR082865A1 (es) | Derivados de triazolo[4,3-a]piridina, y sus usos | |
EA201290654A1 (ru) | Новые замещенные триазольные производные как модуляторы гамма-секретазы | |
PE20121815A1 (es) | Compuestos de pirrolo-pirimidina como inhibidores de cdk4/6 | |
ECSP13012596A (es) | Proceso de elaboración para derivados de pirimidina | |
EA200970510A1 (ru) | Гетеромоноциклическое соединение и его применение | |
MX2014013957A (es) | Derivados de 3,4-dihidro-2h-pirido[1,2-a]pirazin-1,6-diona sustituidos utiles para el tratamiento de la enfermedad de alzheimer (inter alia). | |
CL2015002520A1 (es) | Compuestos novedosos de pirimidina y piridina y su uso. | |
EA201171008A1 (ru) | Новые замещенные бициклические гетероциклические соединения в качестве модуляторов гамма-секретазы | |
PE20160844A1 (es) | Compuestos triciclicos como agentes anticancerigenos | |
UY33458A (es) | Derivados de metoxifenilo heterocíclicamente sustituidos con un grupo oxo, procedimientos para su preparación y uso de los mismos como medicamentos | |
AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
PE20130306A1 (es) | Morfolinopirimidinas y su uso en terapia | |
CR20120410A (es) | Pirrolidina-2-carboxamidas sustituidas | |
EA201490859A1 (ru) | Алкилированные соединения пиперазина в качестве ингибиторов тирозинкиназы брутона | |
PE20191245A1 (es) | Compuestos de tiazolcarboxamidas y piridinacarboxamida utiles como inhibidores de quinasa pim | |
PE20150684A1 (es) | Compuestos triciclicos sustituidos como inhibidores del receptor del factor de crecimiento de fibroblastos (fgfr) | |
HN2012001413A (es) | Derivados de pirazina y su uso en el tratamiento de trastornos neurólogicos | |
ECSP10010419A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos-211 | |
CR20110099A (es) | Pirrolidina-2-carboxamidas sustituidas | |
CY1116885T1 (el) | Υποκατεστημενα παραγωγα κυκλοεξυλομεθυλιου | |
PE20161405A1 (es) | Analogos de cortistatina y sintesis y usos de los mismos | |
EA201400338A1 (ru) | Производные аминопиримидина для применения в качестве модуляторов киназной активности | |
SV2011003997A (es) | Pirimidinas fusionadas | |
UY35182A (es) | ?COMPUESTOS DE HEXAHIDROPIRANO[ 3,4-d][1,3]TIAZIN-2-AMINA? . | |
AR095137A1 (es) | Derivados de 1,2,4-triazol, composiciones que los comprenden y métodos de control de enfermedades fitopatógenas que los emplean por su actividad fungicida |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |